Prevalence of metabolic dysfunction‐associated steatotic liver disease in the Middle East and North Africa

enthalten in: Liver International | 2024

von Younossi, Z. | Golabi, P. | Paik, J. | +5

Response to “Hepatitis delta virus infection in the Middle East”

enthalten in: Liver International | 2023

von Alqahtani, S. | Sanai, F. | Selm, L. | +1

Risk of severe disease and mortality of COVID‐19 in patients with Budd‐Chiari syndrome : A population‐based matched cohort study

enthalten in: Liver International | 2023

von Krishnan, A. | Schneider, C. | Schattenberg, J. | +1

Hepatitis delta virus infection prevalence, diagnosis and treatment in the Middle East : A scoping review

enthalten in: Liver International | 2023

von Lazarus, J. | Al‐Rifai, A. | Sanai, F. | +5

Hepatic ultrastructural features distinguish paediatric Wilson disease from NAFLD and autoimmune hepatitis

enthalten in: Liver International | 2022

von Alqahtani, S. | Chami, R. | Abuquteish, D. | +8

Outcome of liver cancer patients with SARS‐CoV‐2 infection : An International, Multicentre, Cohort Study

enthalten in: Liver International | 2022

von Muñoz‐Martínez, S. | Sapena, V. | Forner, A. | +52

Gulf Cooperation Council states : On the brink of HBV elimination

enthalten in: Liver International | 2021

von Lazarus, J. | Mark, H. | Sanai, F. | +4

Treating paediatric hepatitis C in the era of direct‐acting antiviral agents

enthalten in: Liver International | 2021

von Alqahtani, S. | Colombo, M.